Report
Novo Nordisk oral Wegovy and Eli Lilly orforglipron reportedly set for India in first half of 2027
The Economic Times reports Novo Nordisk’s oral Wegovy and Eli Lilly’s orforglipron are expected in India in the first half of 2027, and that top officials said both products have already been submitted to Indian regulators.
TLDR
The Economic Times reports Novo Nordisk’s oral Wegovy and Eli Lilly’s orforglipron are expected to reach India in the first half of 2027. Doctors cited by ET said pills could expand demand among people who avoid injections and some patients seeking maintenance therapy, but pricing may be crucial in India, and ET’s cited efficacy figures for oral drugs were lower than for injectables.
Combined views
7.7K
1 Source, first seen ago